M E Erwin
Impact in
- Molecular Medicine top 2%
- Antibiotic Resistance in Bacteria
- Clinical Biochemistry top 2%
- Bacterial Identification and Susceptibility Testing
Papers in
- Pharmacology 25
- Antibiotics Pharmacokinetics and Efficacy 24
-
- Antibiotic Resistance in Bacteria 23
- Co-authors
- Ronald N. Jones (39 shared papers)David M. Johnson (8 shared papers)M S Barrett (8 shared papers)Michael A. Pfaller (8 shared papers)Douglas J. Biedenbach (7 shared papers)Ana Espinel‐Ingroff (1 shared paper)Anne Schuchat (1 shared paper)Henry M. Blumberg (1 shared paper)
- Journals
- Journal of Clinical Microbiology (16 papers)Diagnostic Microbiology and Infectious Disease (13 papers)Antimicrobial Agents and Chemotherapy (6 papers)European Journal of Clinical Microbiology & Infectious Diseases (5 papers)Drugs (1 paper)
- Partner nations
- United StatesBrazilIreland
In The Last Decade
M E Erwin
44 papers receiving 887 citations
Peers
Comparison fields: 5 of 74
- Molecular Medicine 292
- Clinical Biochemistry 160
- Infectious Diseases 357
- Applied Microbiology and Biotechnology 36
- Pharmacology 278
Countries citing papers authored by M E Erwin
This map shows the geographic impact of M E Erwin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M E Erwin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M E Erwin more than expected).
Fields of papers citing papers by M E Erwin
This network shows the impact of papers produced by M E Erwin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M E Erwin. The network helps show where M E Erwin may publish in the future.
Co-authors
The 25 scholars most cited alongside M E Erwin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 44 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1996 | 178 | |
| 2 | 1996 | 121 | |
| 3 | 1996 | 93 | |
| 4 | 1997 | 62 | |
| 5 | 1999 | 44 | |
| 6 | 1993 | 41 | |
| 7 | 1992 | 36 | |
| 8 | 1992 | 30 | |
| 9 | 1999 | 27 | |
| 10 | 2000 | 24 | |
| 11 | 1993 | 21 | |
| 12 | 1992 | 20 | |
| 13 | 1999 | 19 | |
| 14 | 1999 | 18 | |
| 15 | 1991 | 17 | |
| 16 | 1994 | 14 | |
| 17 | 1992 | 14 | |
| 18 | 1999 | 13 | |
| 19 | 1999 | 13 | |
| 20 | 1992 | 13 |
About M E Erwin
M E Erwin is a scholar working on Pharmacology, Molecular Medicine, Epidemiology, Infectious Diseases and Clinical Biochemistry, having authored 44 papers that have together received 969 indexed citations. Recurring topics across this work include Antibiotics Pharmacokinetics and Efficacy (24 papers), Antibiotic Resistance in Bacteria (23 papers), Antimicrobial Resistance in Staphylococcus (12 papers), Pneumonia and Respiratory Infections (11 papers), Bacterial Identification and Susceptibility Testing (10 papers), Bacterial Infections and Vaccines (8 papers), Legionella and Acanthamoeba research (5 papers) and Reproductive tract infections research (5 papers). The work is most often cited by research in Molecular Medicine (292 citations), Clinical Biochemistry (160 citations), Infectious Diseases (357 citations), Applied Microbiology and Biotechnology (36 citations) and Pharmacology (278 citations). M E Erwin has collaborated with scholars based in United States, Brazil and Ireland. Frequent co-authors include Ronald N. Jones, David M. Johnson, M S Barrett, Michael A. Pfaller, Douglas J. Biedenbach, Ana Espinel‐Ingroff, Anne Schuchat, Henry M. Blumberg, Wendy Baughman and John Elliot. Their work appears in journals such as Journal of Clinical Microbiology, Diagnostic Microbiology and Infectious Disease, Antimicrobial Agents and Chemotherapy, European Journal of Clinical Microbiology & Infectious Diseases and Drugs.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.